Abstract
In this study we introduce a novel in vitro 'oil-drop' assay system for the measurement of endothelial cell (EC) migration, based on the original concept of the Teflon fence assay (Pratt et al., 1984; Am. J. Pathol. 117: 349–354). An aliquot of 15–20,000 human umbilical vein EC (HUVEC) is pipetted through a layer of mineral oil. The cells readily attach, spread and migrate on the surface of a matrix-coated tissue culture dish as a confluent circular monolayer. Migration is measured as the net increase in the total area covered at 24 hours. We have used this system to quantify EC migration on matrices composed of a mixture of type I collagen and either von Willebrand factor (vWF) or fibronectin (FN) in the presence or absence of tumor necrosis factor α (TNFα). Plating efficiency on both vWF/collagen and FN/collagen, measured by counting cells after attachment and spreading, is about 80%. With this method, migration on vWF/collagen was about 6.4 mm2 and 5.3 mm2 for TNFα-treated and untreated HUVEC, respectively. HUVEC migration on FN/collagen was slightly greater – 6.4 mm2 and 6.5 mm2 with and without TNFα treatment, respectively. During the 24 hour time period, HUVEC numbers increased 30–40% on vWF/collagen, and 60–80% on FN/collagen, with increased proliferation observed with TNF-α treatment. EC proliferation could be completely inhibited by 2 mM hydroxyurea. This assay system has proven useful in our studies to quantify cell migration and proliferation.
Similar content being viewed by others
References
Byzova TV, Rabbani R, D'Souza SE, Plow EF (1998). Role of integrin αvβ3 in vascular biology. Thromb Haemost 80: 726-734.
Pober JS, Cotran RS (1990). The role of endothelial cells in inflammation. Transplantation 50: 537-544.
Shuster CB, Herman IM (1998). The mechanics of vascular cell motility. Microcirculation 5: 239-257.
Lauffenburger DA, Horwitz AF (1996). Cell migration: A physically integrated molecular process. Cell 84: 359-369.
Huttenlocher A, Ginsberg MH, Horwitz AF (1996). Modulation of cell migration by integrin-mediated cytoskeletal linkages and ligand-binding affinity. J Cell Biol 134: 1551-1562.
Albrecht-Buehler G (1977). The phagokinetic tracks of 3T3 cells. Cell 11: 395-404.
Jozaki K, Marucha PT, Despins AW, Kreutzer DL (1990). An in vitro model of cell migration: Evaluation of vascular endothelial cell migration. Anal Biochem 190: 39-47.
Leavesley DI, Schwartz MA, Rosenfeld M, Cheresh DA (1993). Integrin β1-and β3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J Cell Biol 121: 163-170.
Klemke RL, Cai S, Giannini AL, Gallagher PJ, Lanerolle PD, Cheresh DA (1997). Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol 137: 481-492.
Madri JA, Stenn KS (1982). Aortic endothelial cell migration. I. Matrix requirements and composition. Am J Pathol 106: 180-186.
Defilippi P, Truffa G, Stefanuto G, Altruda F, Silengo L, Tarone G (1991). Tumor necrosis factor α and interferon γ modulate the expression of the vitronectin receptor (integrin β3) in human endothelial cells. J Biol Chem 266: 7638-7645.
Pratt BM, Harris AS, Morrow JS, Madri JA (1984). Mechanisms of cytoskeletal regulation. Am J Pathol 117: 349-354.
Cary L, Guan J-L (1999). Functional analysis of FAK and associated molecules in cell migration, vol. 2. Boca Raton, FL, CRC Press LLC.
Lian J, Guoping C, Shapiro SS, Tran L-P, Beacham DA (1999). Glycoprotein Ibα can mediate endothelial cell migration on von Willebrand Factor-containing substrata. Expt'l Cell Res 252: 114-122.
Beacham DA, Wise RJ, Turci SM, Handin RI (1992). Selective inactivation of the Arg-gly-asp-ser (RGDS) binding site in von Willebrand Factor by site-directed mutagenesis. J Biol Chem 267: 3409-3415.
Beacham DA, Cruz MA, Handin RI (1995). Glycoprotein Ib can mediate endothelial cell attachment to a von Willebrand Factor substratum. Thromb Haemost 73: 309-317.
Beacham DA, Tran L-P, Shapiro SS (1997). Cytokine treatment of endothelial cells increases glycoprotein Ibα-dependent adhesion to von Willebrand Factor. Blood 89: 4071-4077.
Konkle BA, Shapiro SS, Asch AS, Nachman RL (1990). Cytokine-enhanced expression of glycoprotein Ibα in human endothelium. J Biol Chem 265: 19833-19838.
Rajagopalan V, Essex DW, Shapiro SS, Konkle BA (1992). Tumor necrosis factor α modulation of glycoprotein Ibα expression in human endothelial and erythroleukemia cells. Blood 80: 153-161.
Wu G, Essex DW, Meloni FJ, Takafuta T, Fujimura K, Konkle BA, Shapiro SS (1997). Human endothelial cells in culture and in vivo express on their surface all four components of the glycoprotein Ib/IX/V complex. Blood 90: 2660-2669.
Maciag T, Hoover GA, Weinstein R (1982). High and low molecular weight forms of endothelial cell growth factor. J Biol Chem 257: 5333-5336
Majack RA, Clowes AW (1984). Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans. J Cell Physiol 118: 253-256.
Bozarth JM, Penno MB, Mousa SA (1997). An improved method for the quantitation of cellular migration: Role of αvβ3 integrin in endothelial and smooth muscle cell migration. Methods in Cell Science 19: 179-187.
Leavesley DI, Ferguson GD, Wayner EA, Cheresh DA (1992). Requirement of the integrin β3 subunit for carcinoma cell spreading or migration on vitronectin and fibrinogen. J Cell Biol 117: 1101-1107.
Lian J, Niewiarowski S, Marcinkiewicz C, Beacham DA (2000). ERK activation is required for GP Ibα-dependent endothelial cell migration. Resubmitted to Blood, 9/00.
Yamada KM (1989). Fibronectins: structure, functions and receptors (review). Curr Opin Cell Biol 1: 956-963.
Feng S, Christodoulides N, Kroll MH (1999). The Glycoprotein Ib/IX complex regulates cell proliferation. Blood 93: 4256-4263.
Rights and permissions
About this article
Cite this article
Cai, G., Lian, J., Shapiro, S.S. et al. Evaluation of endothelial cell migration with a novel in vitro assay system. Methods Cell Sci 22, 107–114 (2000). https://doi.org/10.1023/A:1009864613566
Issue Date:
DOI: https://doi.org/10.1023/A:1009864613566